Oncogenetics training in Brazilian medical genetics residency programs: current landscape and challenges
Oncogenetics focuses on identifying and managing hereditary cancer predisposition, enabling risk-reducing interventions and targeted therapies. This descriptive study evaluated the landscape of oncogenetics training within Medical Genetics Residency Programs in Brazil. Data were collected through online questionnaires and interviews with program supervisors. We assessed rotation availability, timing and duration, clinical and theoretical workload, multidisciplinary care, and competency assessment. Data were analyzed using descriptive statistics. All twelve accredited programs participated. Eleven (92%) offered oncogenetics training, primarily in the third year of residency. While half of the programs provided internal rotations, all allowed external rotations to compensate for local infrastructure limitations. Residents completed a mean of 250.1 practical hours (SD 126.5; range 40-400) over approximately 6.5 months, seeing about 13 patients per week (SD 9.2; range 5-30). Theoretical training averaged 31.3 h (SD 26.8; range 4-70), resulting in a mean total training workload of 258.7 h (SD 159.1; range 4-470). Multidisciplinary care and research opportunities were common; however, formal competency assessments specific to oncogenetics were infrequent. Considerable variability in workload and clinical settings was observed across programs. The findings indicate that oncogenetics is well integrated into Brazilian medical genetics training, aligning with the growing importance of genomic medicine in oncology. Nevertheless, the marked heterogeneity underscores the need for standardized training approaches. The study suggests that establishing inter-institutional networks and formalizing external rotations may help reduce geographic and technological disparities and support more consistent oncogenetics training in medical genetics residency programs across Brazil.
Authors
- Victor Evangelista de Faria Ferraz (ORCID: https://orcid.org/0000-0003-0337-4588)
- Débora Gusmão Melo (ORCID: https://orcid.org/0000-0001-7005-3544)
- Angelina Xavier Acosta (ORCID: https://orcid.org/0000-0003-1494-1373)
- C. A. Souza (ORCID: https://orcid.org/0000-0003-4321-1951)
- Paulo Ricardo Gazzola Zen (ORCID: https://orcid.org/0000-0002-7628-4877)
- Maria Denise Fernandes Carvalho de Andrade (ORCID: https://orcid.org/0000-0003-1890-4721)
- Romina Soledad Heredia
- Carlos Eduardo Steiner (ORCID: https://orcid.org/0000-0001-5148-3063)
- Patrícia Ashton‐Prolla (ORCID: https://orcid.org/0000-0002-5093-4739)
- Chong Ae Kim (ORCID: https://orcid.org/0000-0002-1754-1300)
- Fernando Regla Vargas (ORCID: https://orcid.org/0000-0003-1106-4061)
- Patrícia Santana Correia (ORCID: https://orcid.org/0000-0002-5833-6856)
- Amaro Freire de Queiroz Júnior
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade de Ribeirão Preto (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Complexo Hospitalar Universitário Professor Edgard Santos (BR)
- Centro de Genética Clínica (PT)
- Hospital de Clínicas de Porto Alegre (BR)
- National Institute on Population Medical Genetics (BR)
- Hospital das Clínicas da Universidade Federal de Minas Gerais (BR)
- Instituto Nacional de Saúde (MZ)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Escola Superior de Ciências da Saúde (BR)
- Hospital de Clínicas da Unicamp (BR)
- Hospital Geral de Fortaleza (BR)
- Fundação Oswaldo Cruz (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Journal of Community Genetics
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1007/s12687-026-00916-5
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade Federal do Rio Grande do Sul